Search Browse Earnings

Centessa Pharmaceuticals plc — SlamSEC

Centessa Pharmaceuticals plc

Nasdaq:CNTA

Pharmaceutical Preparations·ALTRINCHAM, CHESHIRE, X0

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$6.9M

FY 2024

Adj. EBITDA

-$170.5M

-2487.6% margin

FY 2024

Net Income

-$151.1M

-2204.7% margin

FY 2024

EPS (Diluted)

-$1.57

FY 2024

Stock Price

$26.09

+0.5%

2026-03-09

52W Range

$9.60 – $30.58

P/E Ratio

-16.6x

Market Cap

$3.5B

Cash

$128.0M

FY 2024

Total Debt

$81.3M

FY 2024

Net Cash

$46.7M

FY 2024

Enterprise Value

$3.5B

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-20.3x

Employees

—

CEO

Accardi Mario Alberto

CFO

Crowley John J